Yanling Zhang

Structure-Based Optimization of Protein Tyrosine Phosphatase 1B Inhibitors:  From the Active Site to the Second Phosphotyrosine Binding Site

Douglas Wilson, Zhao‐Kui Wan, Weixin Xu et al. · Journal of Medicinal Chemistry · 2007 · 164 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression

Sanjun Shi, Lu Han, Li Deng et al. · Journal of Controlled Release · 2014 · 156 citations

Pharmacy, Oncology, Pharmaceutics +16

HIF-1α Inhibition Reverses Multidrug Resistance in Colon Cancer Cells via Downregulation of MDR1/P-Glycoprotein

Jianfang Chen, Zhenyu Ding, Yonghai Peng et al. · PLoS ONE · 2014 · 155 citations · Full text

Medicine, Oncology, Pharmacology +15

Exploiting an Asp-Glu “switch” in glycogen synthase kinase 3 to design paralog-selective inhibitors for use in acute myeloid leukemia

Florence F. Wagner, Lina Benajiba, Arthur J. Campbell et al. · Science Translational Medicine · 2018 · 96 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Discovery of the First Histone Deacetylase 6/8 Dual Inhibitors

David E. Olson, Florence F. Wagner, Taner Kaya et al. · Journal of Medicinal Chemistry · 2013 · 88 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +7